Background: Polypharmacy is a growing concern in the older population. Integrated Residential Assessment Programme (IRAP) was introduced in a selected long-term care (LTC) ward in an effort to switch from paper based documentations to electronic records. IRAP allows remote monitoring of resident's medications and a 3 monthly review by relevant hospital physician. This study aims to establish the prevalence of polypharmacy in a LTC setting and to assess if IRAP reduces polypharmacy. Method: Data was collected from IRAP. For audit purposes, polypharmacy was classified into 3 groups; no polypharmacy (0-4 medicines), polypharmacy (5-9 medicines) and excessive polypharmacy (> = 10 medicines). Medications review results were relayed to
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